名称:
                                Discovery of potent, metabolically stable purine CRF-1 antagonists with differentiated binding kinetic profiles
                             
                            
                                摘要:
                                Optimisation of the potency of a bicyclic CRF antagonist whilst retaining metabolic stability is described. A core change and incorporation of metabolically stable lipophilic groups resulted in a further potency gain without increasing metabolic liability. Pharmacological investigation of binding kinetics led to the identification of compound 25, a sub-nanomolar CRF-1 antagonist with slow dissociation kinetics and an encouraging pharmacokinetic profile. (C) 2011 Elsevier Ltd. All rights reserved.
                             
                                                            
                                    DOI:
                                    10.1016/j.bmcl.2011.08.040